https://endpoints.news/novartis-to-buy-rna-drugmaker-avidity-biosciences-for-12b/
Novartis to buy RNA drugmaker Avidity Biosciences for $12B
Oct 27, 2025 - Novartis to acquire Avidity Biosciences for $12B, gaining access to three neuromuscular drug candidates nearing FDA submission. Deal includes spinout of cardio...
avidity biosciencesnovartis
https://fprimecapital.com/company/avidity-nanomedicines/
Avidity Biosciences - F-Prime Capital
Oct 27, 2025 - Avidity Biosciences (NASDAQ: RNA) is a biotech company pioneering a new class of precision medicines – Antibody-siRNA Conjugates (ASC™) – which combine...
biosciences f primeavidity
https://www.aviditybiosciences.com/
Homepage | Avidity Biosciences
avidity bioscienceshomepage